| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jade Biosciences, Inc. (JBIO) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. JBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.90M | $31.92M | - | |
| CFO | 526.0K | $8.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Dake Benjamin T77 | See Remarks | Sale+OE | 3,432 | $28.01 | $96,119.34 | -72.7% | -94.4% | -90.7% | |
| Mar 19, 2024 | Verwijs Marinus82 | Chief Technical Officer | Sale+OE | 5,300 | $26.08 | $138,242.99 | -65.7% | -93.6% | -90.2% | |
| Mar 18, 2024 | Dake Benjamin T77 | See Remarks | Sale+OE | 35,057 | $25.90 | $908,045.53 | -77.5% | -93.7% | -90.6% | |
| Mar 18, 2024 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 7,000 | $25.87 | $181,056.65 | -49.6% | -93.7% | -90.6% | |
| Mar 13, 2024 | Eldridge George A84 | See Remarks | Sale+OE | 4,067 | $25.03 | $101,814.51 | -50.9% | -17.5% | -90.8% | |
| Mar 11, 2024 | Eldridge George A84 | See Remarks | Sale+OE | 25,933 | $25.03 | $649,205.50 | -76.8% | -11.7% | -89.8% | |
| Mar 7, 2024 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 8,975 | $24.50 | $219,887.50 | -73.4% | -22.5% | -89.6% | |
| Feb 23, 2024 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 511 | $19.50 | $9,964.50 | -13.6% | -12.7% | -87.9% | |
| Feb 20, 2024 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 3,489 | $20.23 | $70,574.51 | -32.0% | +7.3% | -87.2% | |
| Feb 5, 2024 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 4,600 | $17.45 | $80,249.30 | -74.1% | +13.7% | -85.8% |